Family · Pharmaceutical analytical standards
Avatrombopag
An oral thrombopoietin receptor agonist that stimulates platelet production; approved in the United States in May 2018 for adults with chronic liver disease and low platelets who are scheduled for a procedure. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It mimics thrombopoietin, the hormone that controls platelet production and is made mainly by the liver: this is why platelets often fall in chronic liver disease.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
